Changes in glucose tolerance and plasma insulin during lipid-lowering treatment with diet, clofibrate and niceritrol
- 1 June 1982
- journal article
- research article
- Published by Elsevier in Atherosclerosis
- Vol. 43 (2-3) , 177-184
- https://doi.org/10.1016/0021-9150(82)90020-x
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Normalization of Low-Density-Lipoprotein Levels in Heterozygous Familial Hypercholesterolemia with a Combined Drug RegimenNew England Journal of Medicine, 1981
- The effects of colestipol when combined with clofibrate in the treatment of severe hyperlipidemiaAtherosclerosis, 1980
- Effect of combined clofibrate-nicotinic acid treatment in ischemic heart disease An interim reportAtherosclerosis, 1980
- Changes in the fatty acid composition of the plasma lipid esters during lipid-lowering treatment with diet, clofibrate and niceritrol Reduction of the proportion of linoleate by clofibrate but not by niceritrolAtherosclerosis, 1980
- Pronounced lipoprotein lipid reduction obtained by combined lipid-lowering treatment in patients with atherosclerotic diseaseAtherosclerosis, 1979
- Effect of clofibrate on arginine-stimulated glucagon and insulin secretion in manMetabolism, 1974
- CONTROLLED CLINICAL TRIAL OF A NEW BILE ACID‐SEQUESTERING RESIN, COLESTIPOL, IN THE TREATMENT OF HYPERCHOLESTEROLEMIAThe Medical Journal of Australia, 1973
- Radioimmunosorbent assay for proteins. Chemical couplings of antibodies to insoluble dextranImmunochemistry, 1967
- A Methodological Study of the Enzymatic Determination of Glucose in BloodScandinavian Journal of Clinical and Laboratory Investigation, 1963